Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,889,394 papers from all fields of science
Search
Sign In
Create Free Account
Phosphoribosylpyrophosphate synthetase:CCnt:Pt:RBC:Qn
Known as:
?????????????????????? ?????????:????????:??????:??????????:?????
, Phosphoribosylpyrophosphate synthétase:Contenu catalytique:Temps ponctuel:GR:Quantitatif
, Fosforibozilpirofosfat sentetaz:Ktl?çrk:Zml?:Eritrosit:Kant
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Chemical procedure
Erythrocytes
Phosphoribosylpyrophosphate synthetase
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1978
1978
Overproduction disease in man due to enzyme feedback resistance mutation. Purine overproduction in gout due to excessive activity of mutant feedback-resistant phosphoribosylpyrophosphate synthetase.
O. Sperling
,
P. Boer
,
S. Brosh
,
E. Zoref
,
A. De vries
Enzyme
1978
Corpus ID: 36982937
Physiologically superactive phosphoribosylpyrophosphate (PRPP) synthetase, due to feedback resistance mutation, was found in a…
Expand
1975
1975
Phosphoribosylpyrophosphate overproduction, a new metabolic abnormality in the Lesch Nyhan syndrome
G. H. Reem
Science
1975
Corpus ID: 638122
The activity of phosphoribosylpyrophosphate synthetase and the rate of phosphoribosylpyrophosphate accumulation are significantly…
Expand
1973
1973
Human glltamine phosphoribosylpyrophosphate (PP-ribose-P) amidotransferase: kinetic, regulation and configurational changes.
E. Holmes
,
J. Wyngaarden
,
W. Kelley
Advances in Experimental Medicine and Biology
1973
Corpus ID: 45600379
In a large percentage of patients with gout, hyperuricemia is the result of an increase in the rate of purine biosynthesis de…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required